Skip to content

Clinical trials

Amyloidosis trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Country / region: Israel Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20101
20121
20161
20171
20192
20202
20212
20221
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Active, not recruiting2
Terminated2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alnylam Pharmaceuticals3
Ionis Pharmaceuticals, Inc.2
Prothena Biosciences Ltd.2
Alexion Pharmaceuticals, Inc.1
Bellus Health Inc. - a GSK company1
C.T. Development America, Inc.1
Eidos Therapeutics, a BridgeBio company1
Hadassah Medical Organization1
Intellia Therapeutics1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis17
Cardiomyopathies5
Amyloidosis, Familial3
Immunoglobulin Light-chain Amyloidosis3
Alzheimer Disease2
Amyloid Neuropathies, Familial2
Amyloid Neuropathies1
Arthritis, Rheumatoid1
Familial Mediterranean Fever1
Gastrointestinal Diseases1

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.